검색어: atherothrombosis (영어 - 몰타어)

the effectiveness of clopidogrel bms as an anticoagulant was compared with that of aspirin in a study called caprie including around 19,000 patients with atherothrombosis.
l- effikaċja ta ’ clopidogrel bms bħala anticoagulant tqabblet ma ’ dik ta ’ l- aspirina fi studju msejjaħ caprie li fih ħadu sehem madwar 19, 000 pazjent b’ aterotrombożi.

the effectiveness of iscover as an anticoagulant was examined in a study (caprie) of around 19,000 patients with atherothrombosis, where iscover was compared with aspirin.
l- effettività ta ’ iscover bħala antikoagulant ġiet eżaminata fi studju (caprie) ta ’ madwar 19, 000 pazjent b’ aterotrombożi, fejn iscover tqabbel ma ’ aspirina.

clopidogrel bms is taken to prevent blood clots (thrombi) forming in hardened blood vessels (arteries), a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, heart attack, or death).
clopidogrel bms jittieħed biex inaqqas ir-riskju li ċapep tad-demm (trombi) jifformaw fl-arterji mwebbsin (arterji), proċess imsejjaħ aterotrombożi, li jista’ jwassal għal konsegwenzi aterotrombotiċi (bħal puplesija, attakk tal-qalb, jew mewt).